Osvah Pharmaceutical Co. has been incorporated since 40 years ago in 1966, in the name of Iran Merck Co. (Private Joint-stock Co.), and the factory operation has been started since 1969. This company included production, QC Lab, Research, Technical and Engineering, Warehouses, and administrative buildings and departments.
This company was renamed to Osvah Pharmaceutical Co. in March 1982, and changed into a Public Joint-stock Co. in 1991, then was accepted by Tehran Securities & Exchange Organization since March 1994.
Osvah Pharmaceutical Co. as one the pioneers of Iranian Pharmaceutical Industry is wholly trying to be active in developing the society's health level by using modern technologies in compliance with the standards and international criteria. So that, Osvah Pharmaceutical Co. with the approach of treatment services for incurable diseases like Thalassemia, genetic enzyme disorders, MS, cancer, transplant, etc., have added tens of drugs to the Iranian Pharmaceutical category, including Deferasirox (Osveral), nitisinone, Glati